Q2 FY27 summary (quarter ended 30 Sep 2026)
On a year-on-year basis this was a strong quarter. Consolidated revenue increased 24.1% from ₹325.10 crore to ₹403.37 crore, and consolidated net profit rose 54.4% from ₹40.45 crore to ₹62.46 crore. Margins also improved: Q2 EBITDA was ₹78.9 crore, up 60.69% from ₹49.1 crore, with EBITDA margin expanding 450 bps to 19.6% versus 15.1% a year ago (standalone figures). The board announced a ₹1 per share second interim dividend, taking total interim dividend to ₹2 per share.
Despite this, the shares closed at ₹117.46 today, down 8.63%.
Why the market punished it
No outlet has stated the reasons for the fall outright, so the following is my reading of the numbers and the announcement.
- The expansion delay is the main issue. The ₹200 crore expansion project, originally due by September 2026, has been hampered by external factors. The company announced a six-month delay in its ABS capacity expansion due to global supply chain and geopolitical disruptions. The project takes capacity from 75,000 to 100,000 TPA and is now due March 2027. That is roughly a third more capacity, and it was the main reason to expect growth. As recently as April, management confirmed the expansion remained on schedule, with commissioning expected by end-September 2026. A missed timeline after that reassurance hurts credibility.
- The quarter was weaker than Q1. Q1 FY27 had revenue of ₹472 cr and PAT of ₹66 cr. Compared with that, Q2 revenue fell about 15% and PAT fell about 5%. The market had probably taken Q1’s level as the new normal. The margin held up, which suggests lower volumes or prices rather than a cost problem.
- The year-ago comparison was weak. In Q2 FY26, revenue fell 11.4% YoY and net profit fell 12.7% YoY. That makes this year’s +24% and +54% look bigger than the underlying trend.
- The stock had already run up, and growth has been flat. Before results, the market cap was around ₹3,239 crore, up 33.7% in a year, which works out to roughly ₹128–130 per share. Meanwhile, the company has delivered sales growth of -0.25% over the past five years. Annual PAT has been stuck around ₹180 cr for three years. With the new capacity pushed out, the case for a re-rating weakens.
There are positives the market may be overlooking. On current numbers the company is almost debt free, with a dividend payout of around 55%, a P/E of 14.8 and a dividend yield of 3.32%.